Betamethasone Valerate Aerosol, Foam
Product Images NDC 62332-708

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Betamethasone Valerate (NDC 62332-708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4085274d D254 4f17 812e 8a93e4105752 01)

FDA Label Image

50 G Can (4085274d D254 4f17 812e 8a93e4105752 02)

50 G Can (4085274d D254 4f17 812e 8a93e4105752 02)
This text describes a pharmaceutical product containing Betamethasone Valerate foam at a concentration of 0.12%. The product is meant for dermatological use only and should not be used in the eyes. The foam is dispensed from a pressurized can using a hydrocarbon propellant. Instructions are provided for proper application, dosage, and precautions such as avoiding exposure to fire and high temperatures. The product is manufactured by Alembic Pharmaceuticals and comes in a 50-gram dosage. The text also includes storage instructions and warnings about keeping the medication away from children. Additionally, details about the lot number and expiry date are provided.*
FDA Label Image

50 G Carton (4085274d D254 4f17 812e 8a93e4105752 03)

50 G Carton (4085274d D254 4f17 812e 8a93e4105752 03)
Description: The text provides detailed information on Betamethasone Valerate Foam 0.12%. It outlines the composition, application instructions, warnings (flammable content), handling instructions (keep away from eyes and children), and manufacturing details. The foam is for dermatologic use only, not for ophthalmic use. The dosage instructions recommend twice-daily application, and caution against exposure to fire and high temperatures. The product is manufactured by Alembic Pharmaceuticals, Inc. at their facility in NJ, USA, with further manufacturing details provided for their India division. Additionally, there are batch coding, expiration date, and barcode details listed for reference.*
FDA Label Image

Image (4085274d D254 4f17 812e 8a93e4105752 37 1)

FDA Label Image

Image (97821483 4059 4f63 Af9a E7c37b2931ce 35 2)

FDA Label Image

Image (97821483 4059 4f63 Af9a E7c37b2931ce 35 3)

FDA Label Image

Image (97821483 4059 4f63 Af9a E7c37b2931ce 35 4)

FDA Label Image

Image (97821483 4059 4f63 Af9a E7c37b2931ce 35 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.